Your browser doesn't support javascript.
loading
The Anticancer Potential of Apigenin Via Immunoregulation.
Xu, Lu; Zaky, Mohamed Y; Yousuf, Waleed; Ullah, Anwar; Abdelbaset, Gehad R; Zhang, Yingqiu; Ahmed, Osama M; Liu, Shuyan; Liu, Han.
Afiliação
  • Xu L; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zaky MY; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Yousuf W; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Ullah A; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Abdelbaset GR; Molecular Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Egypt.
  • Zhang Y; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Ahmed OM; Molecular Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Egypt.
  • Liu S; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu H; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Curr Pharm Des ; 27(4): 479-489, 2021.
Article em En | MEDLINE | ID: mdl-32660399
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Apigenina / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Assunto da revista: FARMACIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Apigenina / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Assunto da revista: FARMACIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China